- Trying to Block SARS-CoV-2 Transmission With Intranasal VaccinesRubin, RitaJAMA, 2021, 326(17): 1661-1661.
- Repurposing of a clinically used anti-HPV agent to prevent and treat SARS-CoV-2 infection as an intranasal formulationHua, Chen; Ma, Qinhai; Zhu, Yun; Xia, Shuai; Liu, Zezhong; Li, Lin; Lu, Lu; Zhong, Nanshan; Liu, Shuwen*; Yang, Zifeng*; Jiang, Shibo*Signal Transduction and Targeted Therapy, 2021, 6(1): 318.被引 7
- Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2 (vol 31, pg 1011, 2021)Sun, Shiyu; Cai, Yueqi; Song, Tian-Zhang; Pu, Yang; Cheng, Lin; Xu, Hairong; Sun, Jing; Meng, Chaoyang; Lin, Yifan; Huang, Haibin; Zhao, Fang; Zhang, Silin; Gao, Yu; Han, Jian-Bao; Feng, Xiao-Li; Yu, Dan-Dan; Zhu, Yalan; Gao, Pu; Tang, Haidong; Zhao, Jincun; Zhang, Zheng; Yang, Jiaming; Hu, Zhenxiang; Fu, Yang-Xin; Zheng, Yong-Tang; Peng, HuaCell Research, 2021, 31(11): 1222-1222.被引 1
期刊论文
Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2
3被引12阅读
